What does this research mean for the field?

The serotonin reuptake inhibitors duloxetine and escitalopram exhibit broad-spectrum antimicrobial activity, while finasteride significantly disrupts key fungal virulence traits, demonstrating their potential for repurposing as antimicrobial agents. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to assess the antimicrobial and anti-virulence properties of several approved medications against various pathogens.

April 1, 2026Open Access

Repurposing Finasteride and Serotonin Reuptake Inhibitors as Novel Antimicrobials: A Dual-Action Approach to Target Bacterial and Fungal Pathogens

Key Points

This research aims to assess the antimicrobial and anti-virulence properties of several approved medications against various pathogens.
Evaluated antimicrobial efficacy of fluconazole, buspirone, duloxetine, escitalopram, and finasteride.
Tested compounds against Gram-negative bacteria, Gram-positive bacteria, and opportunistic yeasts.
Used growth inhibition and viability assays to measure antimicrobial activity.
Investigated effects on fungal virulence traits like biofilm formation using a model organism.
Duloxetine and escitalopram showed broad-spectrum antimicrobial activity at concentrations below 512 mg/L.
Buspirone was effective against Gram-positive bacteria and C. albicans, exhibiting selective antimicrobial effects.
Finasteride disrupted key virulence traits in yeasts, affecting biofilm formation and infection capacity.

Abstract

Background: The global rise of antimicrobial resistance necessitates the development of innovative therapeutic strategies beyond traditional antibiotics. Drug repurposing offers a time- and cost-effective approach by identifying new antimicrobial applications for existing medications. Thus, this study aimed to investigate the antimicrobial and anti-virulence potential of several clinically approved drugs, including fluconazole, buspirone, duloxetine, escitalopram, and finasteride. Methods: We evaluated the antimicrobial efficacy of the selected compounds against a panel of microorganisms comprising two Gram-negative bacteria (Escherichia coli, Serratia marcescens), two Gram-positive bacteria (Bacillus megaterium, Staphylococcus epidermidis), and two opportunistic yeasts (Candida albicans, Rhodotorula mucilaginosa). Antimicrobial activity was evaluated using growth inhibition and viability assays. Additionally, we investigated the effects of the selected drugs on fungal virulence traits, including biofilm formation and filamentation, and assessed infectivity using a Caenorhabditis elegans host model. Results: Duloxetine and escitalopram demonstrated broad-spectrum antimicrobial activity, inhibiting bacterial and fungal growth at concentrations below 512 mg/L. Buspirone exhibited selective antimicrobial effects, particularly against Gram-positive bacteria and C. albicans. Although finasteride exhibited limited direct antifungal activity, it significantly disrupted key virulence traits in yeasts, including biofilm formation, morphological transitions, and host infection capacity. Conclusion: These findings underscore the potential of serotonin reuptake inhibitors and finasteride as candidates for antimicrobial repurposing. By impairing both microbial viability and pathogenicity, these drugs may provide promising avenues for developing adjunct or alternative therapies against resistant bacterial and fungal pathogens.

AI से पूछें

Bookmark

View Full Paper